CoreCap Advisors’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
TE
BP
MFG
BCG
FFA
GI
BHWM
VCM
APW
CoreCap Advisors's REPL Position: Q2 2026 in Review
CoreCap Advisors increased its Replimune Group (REPL) stake by 11,800% in Q2 2026, buying an estimated $1.44K and bringing the position to 238 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.
CoreCap Advisors first reported a position in REPL in Q3 2025 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- CoreCap Advisors held 238 shares of Replimune Group worth $2.63K as of Q2 2026.
- CoreCap Advisors bought 236 Replimune Group shares in Q2 2026, an estimated $1.44K.
- Replimune Group made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2468 holding.
- CoreCap Advisors first reported a position in Replimune Group in Q3 2025 and has held it in 4 quarters since.
- 16 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.